Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C

This study has been withdrawn prior to enrollment.

Sponsor:

Information provided by (Responsible Party):

Bristol-Myers Squibb

ClinicalTrials.gov Identifier:

NCT01447394

First received: October 4, 2011

Last updated: February 2, 2012

Last verified: February 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	August 2014
Estimated Primary Completion Date:	March 2014 (Final data collection date for primary outcome measure)